10-Q Filing

VIEWBIX INC. CIK: 797542 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001493152-19-012305`
Period End Date	20190630
Filing Date	20190814
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	vbix-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 37 Cash Flow Statement 55 Stockholders Equity 26

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.30K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$499.92K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Short term investment	`ShortTermInvestments`	$17.24K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short term investment	`ShortTermInvestments`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$18.94K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$41.52K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$558.68K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	490.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	490.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$252.24K	USD	Point-in-time
Total assets	`Assets`	$252.24K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.39M	shares	Point-in-time
Total assets	`Assets`	$558.68K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.39M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$13.12K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$105.85K	USD	Point-in-time
Employee payable	`EmployeeRelatedLiabilitiesCurrent`	-	USD	Point-in-time
Employee payable	`EmployeeRelatedLiabilitiesCurrent`	$7.06K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$10.56K	USD	Point-in-time
Short term portion of convertible notes (Note 2)	`ConvertibleNotesPayableCurrent`	$503.22K	USD	Point-in-time
Short term portion of convertible notes (Note 2)	`ConvertibleNotesPayableCurrent`	$485.45K	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$469.52K	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$469.52K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$975.15K	USD	Point-in-time
Total liabilities	`Liabilities`	$975.15K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.09M	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding at June 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding at June 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 490,000,000 shares authorized; 7,485,695 shares issued and outstanding at June 30, 2019 and 7,385,695 December 31, 2018. (Note 3)	`CommonStockValue`	$11.07K	USD	Point-in-time
Common stock, $0.0001 par value; 490,000,000 shares authorized; 7,485,695 shares issued and outstanding at June 30, 2019 and 7,385,695 December 31, 2018. (Note 3)	`CommonStockValue`	$11.07K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.34K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.34K	USD	Point-in-time
Additional paid-in capital (Note 3)	`AdditionalPaidInCapital`	$41.22M	USD	Point-in-time
Additional paid-in capital (Note 3)	`AdditionalPaidInCapital`	$41.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-41.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-41.98M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-416.48K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.59M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-836.90K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$252.24K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$558.68K	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$630.97K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$16.04K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$266.95K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.45K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$249.30K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$356.51K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$440.51K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.42M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.05M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$623.47K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$465.96K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$265.34K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-265.34K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-465.96K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.05M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-623.47K	USD	1 Quarter
Finance income (expense), net	`NonoperatingIncomeExpense`	$-2.62M	USD	1 Quarter
Finance income (expense), net	`NonoperatingIncomeExpense`	$-3.83K	USD	1 Quarter
Finance income (expense), net	`NonoperatingIncomeExpense`	$112.14K	USD	2 Qtrs
Finance income (expense), net	`NonoperatingIncomeExpense`	$-21.99M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-353.83K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-25.01M	USD	Annual
Net loss	`NetIncomeLoss`	$-24.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-269.17K	USD	1 Quarter
Basic and diluted net loss per share:	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
Basic and diluted net loss per share:	`EarningsPerShareBasicAndDiluted`	$-0.77	USD	1 Quarter
Basic and diluted net loss per share:	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Basic and diluted net loss per share:	`EarningsPerShareBasicAndDiluted`	$-6.93	USD	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.45M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.23M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.42M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.47M	shares	2 Qtrs

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-353.83K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-25.01M	USD	Annual
Net loss	`NetIncomeLoss`	$-24.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-269.17K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$17.77K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$14.29K	USD	2 Qtrs
Interest and amortization of discount on convertible notes	`InterestAndAmortizationOfDiscountOnConvertibleNotes`	$523.48K	USD	2 Qtrs
Interest and amortization of discount on convertible notes	`InterestAndAmortizationOfDiscountOnConvertibleNotes`	-	USD	2 Qtrs
(Profit) Loss from marketable securities	`MarketableSecuritiesGainLoss`	$-2.37K	USD	2 Qtrs
(Profit) Loss from marketable securities	`MarketableSecuritiesGainLoss`	$8.32K	USD	2 Qtrs
Shares and warrants issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$79.33K	USD	2 Qtrs
Shares and warrants issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.04M	USD	2 Qtrs
Finance loss arising from change in terms of convertible notes	`FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes`	$21.47M	USD	2 Qtrs
Finance loss arising from change in terms of convertible notes	`FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes`	$-145.93K	USD	2 Qtrs
Decrease in net liabilities for sale	`IncreaseInNetLiabilitiesForSale`	$53.38K	USD	2 Qtrs
Decrease in net liabilities for sale	`IncreaseInNetLiabilitiesForSale`	-	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$51.08K	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$85.67K	USD	2 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	2 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInContractWithCustomerLiability`	$50.00K	USD	2 Qtrs
Increase in accrued interest	`IncreaseDecreaseInInterestPayableNet`	-	USD	2 Qtrs
Increase in accrued interest	`IncreaseDecreaseInInterestPayableNet`	$10.56K	USD	2 Qtrs
Decrease in other receivables	`IncreaseDecreaseInOtherReceivables`	$-12.22K	USD	2 Qtrs
Decrease in other receivables	`IncreaseDecreaseInOtherReceivables`	$-22.57K	USD	2 Qtrs
Net cash used operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-935.19K	USD	2 Qtrs
Net cash used operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-281.50K	USD	2 Qtrs
Selling of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$14.88K	USD	2 Qtrs
Selling of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$14.88K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from sale of common stock and warrants (net of issuance expenses)	`ProceedsFromIssuanceOfCommonStock`	$1.94M	USD	2 Qtrs
Proceeds from sale of common stock and warrants (net of issuance expenses)	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Exercise of options	`ProceedsFromStockOptionsExercised`	$63.00	USD	2 Qtrs
Exercise of options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Issuance of convertible note	`ProceedsFromShortTermDebt`	-	USD	2 Qtrs
Issuance of convertible note	`ProceedsFromShortTermDebt`	$100.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.04M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.11M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-266.62K	USD	2 Qtrs
Cash and cash equivalents - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.96K	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.11M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$233.30K	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$499.92K	USD	Point-in-time
Cash and cash equivalents - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.96K	USD	Point-in-time
Cash and cash equivalents - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.11M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$233.30K	USD	Point-in-time
Cash and cash equivalents - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$499.92K	USD	Point-in-time
Increase in deferred revenues against short-term investment	`IncreaseInDeferredRevenuesAgainstShorttermInvestment`	-	USD	2 Qtrs
Increase in deferred revenues against short-term investment	`IncreaseInDeferredRevenuesAgainstShorttermInvestment`	$50.00K	USD	2 Qtrs
Issuance of shares in respect of proceeds received during 2017	`IssuanceOfSharesInRespectOfProceedsReceived`	$-80.00K	USD	2 Qtrs
Issuance of shares in respect of proceeds received during 2017	`IssuanceOfSharesInRespectOfProceedsReceived`	-	USD	2 Qtrs
Common stock issued pursuant to convertible note	`CommonStockIssuedPursuantToConvertibleNote`	-	USD	2 Qtrs
Common stock issued pursuant to convertible note	`CommonStockIssuedPursuantToConvertibleNote`	$85.22K	USD	2 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-416.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$-836.90K	USD	Point-in-time
Common stock and warrants issued for cash	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	-	USD	2 Qtrs
Common stock and warrants issued for cash	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$1.94M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$51.30K	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.00M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$51.30K	USD	Point-in-time
Common stock issued for services, shares	`StockIssuedDuringPeriodSharesIssuedForServices`	100,000.00	shares	Point-in-time
Warrants issued for services	`AdjustmentOfWarrantsGrantedForServices`	$146.38K	USD	Annual
Warrants issued for services	`AdjustmentOfWarrantsGrantedForServices`	$28.04K	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$63.00	USD	Annual
Issuance of new convertible note with a beneficial conversion feature	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$100.00K	USD	Annual
Partial conversion of convertible note to shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne`	$555.39K	USD	Annual
Change in the terms of Convertible Note	`ChangeInTermsOfConvertibleNote`	$22.58M	USD	Annual
Cancellation of Preferred Shares	`StockRepurchasedDuringPeriodValue`	$150.00K	USD	Annual
Issuance of Shares in respect of proceeds received during 2017	`IssuanceOfSharesInRespectOfProceedsReceivedValue`	-	USD	Annual
Extension of convertible note	`AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote`	$-145.93K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-353.83K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-25.01M	USD	Annual
Net loss	`NetIncomeLoss`	$-24.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-269.17K	USD	1 Quarter
Balance	`StockholdersEquity`	$-416.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$-836.90K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.